Global Industry Analysts, Inc., April 2010, Pages: 506
II-1
Current Scenario and Outlook II-1
Asians Lead in Liver Cancer Prevalence and Incidence II-1
Table 1: Incidence and Mortality of Liver Cancer in Select
Countries: 2007 (includes corresponding Graph
Axis Research Mind, July 2010, Pages: 468
& cartilage, cardiac, skin, diabetes, blood disorders, neuro, cancer, digestive system, drug development, eyes, injuries, reproductive system and others.
The report focuses on the major current market trends
TriMark Publications, Jan 2011, Pages: 156
Innovation
2.2.3 Government Funding
2.2.4 Pharmaceutical Development
2.3 Outlook for Tumor Markers
2.4 The Cancer Market
3. Cervical Cytology Testing Overview
3.1 Sector Background
3
TriMark Publications, March 2011, Pages: 309
Women 73
4.3.2.3 Breast Cancer and Mammography in African-Americans 74
4.3.2.4 Breast Cancer and Mammography in Asian Pacific Islanders 75
4.3.2.5 Breast Cancer and Mammography in Native Americans 76
4
Decision Resources, Inc., April 2011, Pages: 41
Pharma Group
- AsianCancer Research Group
- Astellas Pharma
- Astellas Pharma Hong Kong
- Astra
- AstraZeneca Hong Kong
- Baxter
- Bayer Healthcare
- Bayer HealthCare Hong Kong
- Bayer Healthcare
RNCOS E-Services Private Limited, Dec 2011, Pages: 60
RNA Market Outlook”, the global research on miRNA is expected to grow at a stupendous rate in the coming years. Both, private and public sectors are stepping forward to provide huge financial support to fund
Global Industry Analysts, Inc., Oct 2006, Pages: 563
Outlook & Trends II-1
Targeted Therapies Bridge Therapeutic Gap II-1
Significant Unmet Medical Need Drives Growth II-1
Herceptin Makes Headway as a Breakthrough Breast Cancer
Therapeutic II-2
Aromatase
Global Industry Analysts, Inc., Jan 2011, Pages: 442
. MARKET OUTLOOK
Gene Therapy - Promising Therapy for Future?
Approved Gene Therapies Fail to Gather Momentum
Manufacturers Eye International Markets
3. MARKET DYNAMICS/TRENDS
2009 - A Tumultuous Year
Markets and Markets, May 2010, Pages: 193
Cancer is recognized as a major cause of mortality world over; accounting for 7.4 million (or 13%) of all deaths in 2004. The WHO estimates the incidence of cancer to continue rising to reach
Bizacumen Inc., Nov 2009, Pages: 435
of therapeutic vaccines capable of fighting diseases such as cancer and AIDS among others.
These and other market data and trends are presented in "Human Vaccines: Global Market Opportunities" by BizAcumen, Inc
Global Industry Analysts, Inc., Jan 2011, Pages: 804
)
Table 45: US Pediatric Vaccines by Type in terms of
Percent of Doses: 2000-2005 (includes corresponding
Graph/Chart)
‘Bright’ Outlook for Therapeutic Vaccines
Select Cancer Vaccines in Pipeline
Markets and Markets, Aug 2011, Pages: 278
directed towards fast cancer detection and therapy.
Cross border collaboration across most of the biotech companies has spurred the growth of the biochip market in the Asian subcontinent. Private equity
Markets and Markets, Sep 2009, Pages: 256
by the demand from the baby boomer generation in the U.S., and from Asia’s emerging IT industry. Biomarker applications are increasing in cancer diagnosis as novel tools are being developed to increase
Koncept Analytics, Dec 2010, Pages: 45
to experience sustained demand, due to the increased usage of X-rays to diagnose internal injuries, cancer, developmental disorders, spinal trauma, dental condition and to detect breast cancers. With the advent
Axis Research Mind, May 2011, Pages: 692
to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR
Markets and Markets, May 2011, Pages: 331
including life sciences research, clinical diagnostics, biodefense, and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis
Markets and Markets, Sep 2009, Pages: 189
and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 60 market tables for various geographic regions covering the sub-segments and micro-markets
